Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Human Molecular Genetics

• Publication date

  2000-01-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/HMG/9.2.237PMID 10607834
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Evaluation of the protein truncation test and mutation detection in the NF1 gene: mutational analysis of 15 known and 40 unknown mutations

  1999influential reference
• A novel mutation L1425p in the GAP‐region of the NF1 gene detected by temperature gradient gel electrophoresis (TGGE);

  1999cited by this paper
• Prenatal diagnosis of sporadic neurofibromatosis type 1 (NF1) by RNA and DNA analysis of a splicing mutation

  1999cited by this paper
• Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences.

  1999cited by this paper
• A clinical variant of neurofibromatosis type 1: familial spinal neurofibromatosis with a frameshift mutation in the NF1 gene.

  1998cited by this paper
• Neurofibromatosis type 1 (NF1): a protein truncation assay yielding identification of mutations in 73% of patients.

  1998cited by this paper
• The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-->T mutation.

  1998cited by this paper
• Nearby stop codons in exons of the neurofibromatosis type 1 gene are disparate splice effectors.

  1998cited by this paper
• Somatic mosaicism: a common cause of classic disease in tumor-prone syndromes? Lessons from type 2 neurofibromatosis.

  1998cited by this paper
• Structural analysis of the GAP‐related domain from neurofibromin and its implications

  1998cited by this paper
• RNA processing and clinical variability in neurofibromatosis type I (NF1).

  1997cited by this paper
• Deletion of the entire NF1 gene causing distinct manifestations in a family.

  1997cited by this paper
• Rescue of a Drosophila NF1 mutant phenotype by protein kinase A.

  1997cited by this paper
• Characterisation of two different nonsense mutations, C6792A and C6792G, causing skipping of exon 37 in the NF1 gene

  1997cited by this paper
• Somatic mosaicism for deletion of the entire NF1 gene identified by FISH

  1997cited by this paper
• Four frameshift mutations in neurofibromatosis type 1 caused by small insertions.

  1997cited by this paper
• Confirmation of a double-hit model for the NF1 gene in benign neurofibromas.

  1997cited by this paper
• Identification and mapping of type 1 neurofibromatosis (NF1) homologous loci.

  1996cited by this paper
• Somatic mosaicism in a patient with neurofibromatosis type 1.

  1996cited by this paper
• The detection of contiguous gene deletions at the neurofibromatosis 1 locus with fluorescence in situ hybridization.

  1996cited by this paper
• A cytogenetic deletion, del(17)(q11.22q21.1), in a patient with sporadic neurofibromatosis type 1 (NF1) associated with dysmorphism and developmental delay.

  1996cited by this paper
• Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene

  1996cited by this paper
• Long RT-PCR of the entire 8.5-kb NF1 open reading frame and mutation detection on agarose gels.

  1996cited by this paper
• Two novel mutations affecting mRNA splicing of the neurofibromatosis type 1 (NF1) gene

  1996cited by this paper
• Genomic organization of the neurofibromatosis 1 gene (NF1).

  1995cited by this paper
• Characterisation of a novel splice donor mutation affecting position +1 in intron 18 of the NF-1 gene.

  1995cited by this paper
• On unequal allelic expression of the neurofibromin gene in neurofibromatosis type 1.

  1995influential reference
• Characterisation of germline mutations in the neurofibromatosis type 1 (NF1) gene.

  1995cited by this paper
• Deletion of the entire NF1 gene detected by the FISH: four deletion patients associated with severe manifestations.

  1995cited by this paper
• Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5' part of the gene.

  1995cited by this paper
• Two recurrent nonsense mutations and a 4 bp deletion in a quasi-symmetric element in exon 37 of the NF1 gene

  1995cited by this paper
• Identification of neurofibromatosis 1 (NF1) homologous loci by direct sequencing, fluorescence in situ hybridization, and PCR amplification of somatic cell hybrids.

  1995cited by this paper
• Distribution of 13 truncating mutations in the neurofibromatosis 1 gene.

  1995cited by this paper
• A deletion in the 5 ′-region of the neurofibromatosis type 1 (NF1) gene

  1994cited by this paper
• DNA sequences in the promoter region of the NF1 gene are highly conserved between human and mouse.

  1994cited by this paper
• Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients.

  1994cited by this paper
• Neurofibromatosis type 1 due to germ-line mosaicism in a clinically normal father.

  1994cited by this paper
• Characterization of four mutations in the neurofibromatosis type 1 gene by denaturing gradient gel electrophoresis (DGGE).

  1994cited by this paper
• Two NF1 mutations: Frameshift in the GAP‐related domain, and loss of two codons toward the 3′ end of the gene

  1994cited by this paper
• The Neurofibromatoses : a pathogenetic and clinical overview

  1994cited by this paper
• Novel alleles, hemizygosity and deletions at an Alu-repeat within the neurofibromatosis type 1 (NF1) gene.

  1993cited by this paper
• An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes.

  1993cited by this paper
• Neurofibromatosis type 1 (NF1): the search for mutations by PCR-heteroduplex analysis on Hydrolink gels.

  1993cited by this paper
• Identification and characterization of sporadic and inherited mutations in exon 31 of the neurofibromatosis (NF1) gene

  1993cited by this paper
• Mouse neurofibromatosis type 1 cDNA sequence reveals high degree of conservation of both coding and non-coding mRNA segments.

  1993cited by this paper
• Neurofibromatosis: Phenotype, Natural History and Pathogenesis

  1993cited by this paper
• Human Gene Mutation

  1993cited by this paper
• The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences

  1992cited by this paper
• cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product.

  1991cited by this paper
• Recurrence of a nonsense mutation in the NF1 gene causing classical neurofibromatosis type 1

  1991cited by this paper
• The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21.

  1990cited by this paper
• Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients.

  1990cited by this paper
• A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations.

  1990cited by this paper
• The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae.

  1990cited by this paper
• The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins.

  1990cited by this paper
• NIH conference. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update.

  1990cited by this paper
• Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

  1990cited by this paper
• A simple salting out procedure for extracting DNA from human nucleated cells.

  1988cited by this paper
• RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression.

  1987influential reference

• Substitutions of nucleotides at the 3' ends of COL6A1/2/3 exons induce exon skipping associated with collagen VI-related muscular dystrophies and therapeutic strategies.

  2025cites this paper
• From Mutation to Manifestation: Evaluation of a PKLR Gene Truncation Caused by Exon Skipping in a Schnauzer Terrier

  2025cites this paper
• Neurofibromatosis type 1 (NF1)-related ocular signs: new insights on their prevalence, incidence and genotype-phenotype correlation in NF1 children.

  2025cites this paper
• The nature and pathological impact of the c.1748A > G variant of the neurofibromin 1 gene.

  2025cites this paper
• Synonymous and non-synonymous variants at splice junctions can disrupt splicing and are frequently linked to disease associated loss of function genes

  2025cites this paper
• RNA variant assessment using transactivation and transdifferentiation

  2024cites this paper
• Genotype–Phenotype Correlation in Neurofibromatosis Type 1: Evidence for a Mild Phenotype Associated with Splicing Variants Leading to In-Frame Skipping of NF1 Exon 24 [19a]

  2024cites this paper
• Trapezius Island Myocutaneous Flap for Head, Neck, and Facial Reconstruction in Neurofibromatosis Type 1-Associated Plexiform Neurofibromas

  2024cites this paper
• Cost-effective Whole Exome Sequencing discovers pathogenic variant causing Neurofibromatosis type 1 in a family from Jammu and Kashmir, India

  2023cites this paper
• Pathogenicity evaluation of variants of uncertain significance at exon-intron junction by splicing assay in patients with Mowat-Wilson syndrome.

  2023cites this paper
• Nf1 in Heart Development-a Potential Causative Gene for Congenital Heart Disease: A Narrative Review.

  2023cites this paper
• Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome

  2023cites this paper
• Analysis of BRCA1 and BRCA2 alternative splicing in predisposition to ovarian cancer.

  2023cites this paper
• The Contribution of Oxidative Stress to NF1-Altered Tumors

  2023cites this paper
• An intronic RNA element modulates Factor VIII exon-16 splicing

  2023cites this paper
• Annual Review of Genomics and Human Genetics: DECIPHER: Improving Genetic Diagnosis Through Dynamic Integration of Genomic and Clinical Data

  2023cites this paper
• Evaluation of Molecular and Clinical Findings in Children With Neurofibromatosis Type 1: Identification of 15 Novel Variants.

  2023cites this paper
• The identification of protein and RNA interactors of the splicing factor Caper in the adult Drosophila nervous system

  2023cites this paper
• A novel de novo canonical splice site mutation in the PTCH1 gene in a male patient with mild psychomotor retardation and autistic traits: a case report

  2023cites this paper
• A novel stop-gain NF1 variant in neurofibromatosis type 1 and bilateral optic atrophy without optic gliomas

  2023cites this paper
• The Contribution of COL4A5 Splicing Variants to the Pathogenesis of X-Linked Alport Syndrome

  2022cites this paper
• Bibliometric analysis of the top 100 most-cited articles in neurofibromatosis

  2022influential citation
• Phenotype‐driven approaches to enhance variant prioritization and diagnosis of rare disease

  2022cites this paper
• Lessons from 17β-HSD3 deficiency: clinical spectrum and complex molecular basis in Chinese patients.

  2022cites this paper
• Empirical prediction of variant-activated cryptic splice donors using population-based RNA-Seq data

  2022cites this paper
• Prevalence, parameters, and pathogenic mechanisms for splice-altering acceptor variants that disrupt the AG exclusion zone

  2022cites this paper
• Characterization of transcription factor activator pretein-1 (AP-1) and its association with cold tolerance in Pinctada fucata martensii.

  2022cites this paper
• High‐yield identification of pathogenic NF1 variants by skin fibroblast transcriptome screening after apparently normal diagnostic DNA testing

  2022cites this paper
• Comparison of In Silico Tools for Splice-Altering Variant Prediction Using Established Spliceogenic Variants: An End-User's Point of View

  2022cites this paper
• Non-canonical splice junction processing increases the diversity of RBFOX2 splicing isoforms.

  2022cites this paper
• Implications of mosaicism in variant interpretation: A case of a de novo homozygous NF1 variant.

  2021cites this paper
• Analysis of the features of neurofibromatosis type 1 in the Republic of Bashkortostan

  2021cites this paper
• Novel Compound Missense and Intronic Splicing Mutation in ALDH18A1 Causes Autosomal Recessive Spastic Paraplegia

  2021cites this paper
• Mutational spectrum of NF1 gene in 24 unrelated Egyptian families with neurofibromatosis type 1

  2021cites this paper
• Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq

  2021cites this paper
• Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of NF1 Variants

  2021cites this paper
• Empirical prediction of variant-associated cryptic-donors with 87% sensitivity and 95% specificity

  2021cites this paper
• Splicing in the Diagnosis of Rare Disease: Advances and Challenges

  2021cites this paper
• Case Report: A Synonymous Mutation in NF1 Located at the Non-canonical Splicing Site Leading to Exon 45 Skipping

  2021cites this paper
• ECNano: A cost-effective workflow for target enrichment sequencing and accurate variant calling on 4800 clinically significant genes using a single MinION flowcell

  2021cites this paper
• Identification of Deep-Intronic Splice Mutations in a Large Cohort of Patients With Inherited Retinal Diseases

  2021cites this paper
• Neurofibromatosis type 1: results of our own study (Republic of Bashkortostan)

  2021cites this paper
• Decoding the Role of DVL1 in Intracranial Meningioma

  2021cites this paper
• Infantile‐onset myoclonic developmental and epileptic encephalopathy: A new RARS2 phenotype

  2021cites this paper
• Pathogenic noncoding variants in the neurofibromatosis and schwannomatosis predisposition genes

  2021influential citation
• Last Nucleotide Substitutions of COL4A5 Exons Cause Aberrant Splicing

  2021cites this paper
• Unraveling the molecular basis underlying nine putative splice site variants of von Willebrand factor

  2021cites this paper
• Interpretable prioritization of splice variants in diagnostic next-generation sequencing

  2021cites this paper
• Genomics of Peripheral Nerve Sheath Tumors Associated with Neurofibromatosis Type 1

  2020cites this paper
• Перспективы исследования нейрофиброматоза I типа в Республике Башкортостан

  2020cites this paper
• Outlook for Neurofi bromatosis Type I Research in the Republic of Bashkortostan

  2020cites this paper
• Multidisciplinary Approach to Neurofibromatosis Type 1

  2020influential citation
• Human Mutation

  2020cites this paper
• Splicing and Alternative Splicing and the Impact of Mechanics

  2020cites this paper
• Molecular Diagnosis for NF1

  2020cites this paper
• Genetics and Pathway in Neurofibromatosis Type 1

  2020cites this paper
• RNA splicing analysis in genomic medicine.

  2019cites this paper
• Human Mutation

  2019cites this paper
• Functional analysis of 22 splice-site mutations in the PHEX, the causative gene in X-linked dominant hypophosphatemic rickets.

  2019cites this paper
• Clinical and molecular characteristics of thirty NF1 variants in Chinese patients with neurofibromatosis type 1

  2019cites this paper
• Structure-based and evolutionary analyses of alternative splicing patterns in carbonic anhydrases

  2019cites this paper
• The Deletion-Insertion model applied to the genome rearrangement problem

  2019cites this paper
• Molecular Classification of Neuroendocrine Tumors of the Thymus.

  2019cites this paper
• Developmental Disorders

  2019cites this paper
• Genome‐wide DNA methylation and RNA analyses enable reclassification of two variants of uncertain significance in a patient with clinical Kabuki syndrome

  2019cites this paper
• Clinical and Genetic Findings in Children with Neurofibromatosis Type 1, Legius Syndrome, and Other Related Neurocutaneous Disorders

  2019cites this paper
• Two Novel NF1 Pathogenic Variants Causing the Creation of a New Splice Site in Patients With Neurofibromatosis Type I

  2019cites this paper
• TYPE 1NEUROFIBROMATOSIS AND EFFECTS ON THE STOMATOGNATIC SYSTEM

  2018cites this paper
• The contribution of alternative splicing to genetic risk for psychiatric disorders

  2018cites this paper
• Roles of Smads Family and Alternative Splicing Variants of Smad4 in Different Cancers

  2018cites this paper
• Pathogenicity and selective constraint on variation near splice sites

  2018cites this paper
• Whole‐Exome Sequencing Identifies an Intronic Cryptic Splice Site in SERPINF1 Causing Osteogenesis Imperfecta Type VI

  2018cites this paper
• Novel and Recurring Disease-Causing NF1 Variants in Two Chinese Families with Neurofibromatosis Type 1

  2018cites this paper
• A Novel Synonymous Variant in the AVP Gene Associated with Autosomal Dominant Familial Neurohypophyseal Diabetes Insipidus Causes Partial RNA Missplicing

  2018cites this paper
• The biology of cutaneous neurofibromas

  2018cites this paper
• Neurofibromatosis type I: mutation spectrum of NF1 in spanish patients

  2018cites this paper
• Classification of Genetic Variants

  2018cites this paper
• The contribution of non-canonical splicing mutations to severe dominant developmental disorders

  2018cites this paper
• Neurofibromin level directs RAS pathway signaling and mediates sensitivity to targeted agents in malignant peripheral nerve sheath tumors

  2018cites this paper
• Clinical characteristics and NF1 gene mutation analysis of three successive generations in three different Indian families with neurofibromatosis type 1 and peripheral nerve sheath tumours.

  2018cites this paper
• Computational Modelling of Human Transcriptional Regulation by an Information Theory-based Approach

  2018cites this paper
• Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers

  2017cites this paper
• Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844–848

  2017cites this paper
• Investigation of the mechanisms of action of exonic splicing enhancers using single molecule methods

  2017cites this paper
• Gene therapy with modified U1 small nuclear RNA

  2017cites this paper
• De novo indels within introns contribute to ASD incidence

  2017cites this paper
• Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches.

  2017cites this paper
• RNA splicing in human disease and in the clinic.

  2017cites this paper
• Investigation of Gene Splicing Variants Contributing Risk to Psychiatric Disorders

  2017cites this paper
• Investigating the effect of 28 BRCA1 and BRCA2 mutations on their related transcribed mRNA

  2016cites this paper
• Síndrome de cáncer de mama y ovario hereditario: Estudio in vitro de variantes BRCA1 y BRCA2 de significado biológico desconocido y búsqueda de nuevos genes responsables de este síndrome

  2016cites this paper
• Transcriptome profiling identifies differentially expressed genes in systemic lupus erythematosus specific induced pluripotent stem cells from urine

  2016cites this paper
• Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene

  2016cites this paper
• Diagnostic value of multiple café‐au‐lait macules for neurofibromatosis 1 in Chinese children

  2016cites this paper
• Clinical and Molecular Characterization of NF1 Patients

  2016cites this paper
• Bioinformatics tools for discovery and functional analysis of single nucleotide polymorphisms.

  2015cites this paper
• A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1

  2015cites this paper
• A Unified Framework for the Prioritization of Variants of Uncertain Significance in Hereditary Breast and Ovarian Cancer Patients

  2015cites this paper
• High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype–Phenotype Correlation

  2015cites this paper
• Advances in Molecular Diagnosis of Neurofibromatosis Type 1.

  2015cites this paper